C4 Therapeutics (CCCC)
NASDAQ:CCCC
US Market
Holding CCCC?
Track your performance easily

C4 Therapeutics (CCCC) Balance Sheet

440 Followers

C4 Therapeutics Balance Sheet

C4 Therapeutics's total assets for Q3 2024 were $376.06M, a decrease of -1.32% from the previous quarter. CCCC total liabilities were $133.40M for the fiscal quarter, a -0.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 376.45M$ 430.84M$ 506.76M$ 400.14M$ 118.26M
Total Liabilities
$ 130.34M$ 141.61M$ 117.16M$ 119.35M$ 230.22M
Total Equity Gross Minority
$ 246.10M$ 289.22M$ 389.61M$ 280.79M$ -111.96M
Total Capitalization
$ 311.87M$ 605.79M$ 775.73M$ 290.84M$ -111.96M
Preferred Stock Equity
----$ 111.00M
Capital Lease Obligations
---$ 12.87M$ 13.75M
Currency in USD

C4 Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis